Search clinical trials for: Multi-allergen oral immunotherapy

Total 21098 results

Alladapt Immunotherapeutics, Inc.

Completed

ADP101 for Oral Immunotherapy in Food-Allergic Children and Adults

Food Allergy

United States
Alladapt Immunotherapeutics, Inc.

Terminated

Open-label Extension Study of ADP101

Food Allergy

United States
National Institute of Allergy and Infectious Diseases...
Genentech, Inc.; Novartis Pharmaceuticals; Rho Federal Systems Division, Inc.

Active, not recruiting

Omalizumab as Monotherapy and as Adjunct Therapy to Multi-Allergen OIT in Food Allergic Participants (OUtMATCH)

Peanut Allergy | Multi-food Allergy

United States
Children's Hospital of Philadelphia

Recruiting

Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy

Eosinophilic Esophagitis (EoE)

United States
Inhibrx, Inc.

Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

Head and Neck Squamous Cell Carcinoma (HNSCC)

United States
Murdoch Childrens Research Institute

Recruiting

Analysing HIgh Dose Probiotic Peanut Oral Immunotherapy (PPOIT) and High Dose Peanut Oral Immunotherapy (OIT) Versus LOw Dose Peanut OIT for Peanut Allergy (HILO)

Peanut Allergy

Australia
Medical University of Warsaw

Recruiting

Efficacy and Safety of Low-dose Sesame Oral Immunotherapy in Pediatric Patients

Food Allergy

Poland
McGill University Health Centre/Research Institute...
The Hospital for Sick Children

Recruiting

Investigating Modified Protocols of Oral Immunotherapy to Validate Efficacy and Safety (IMPROVES)

Egg Allergy | Peanut Allergy | Milk Allergy, Cow's

Canada
Sun Yat-sen University

Recruiting

SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx

SBRT

China
Chinese University of Hong Kong

Recruiting

Randomized Controlled Trial for Wheat Oral Immunotherapy (WOIT-RCT)

Children | Allergy;Food | Wheat Allergy

Hong Kong
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); AAAAI Foundation

Recruiting

Thresholds In Food Allergy evaluaTion And predictioN (TITAN)

Food Allergy | Tree Nut Allergy

Canada
Mahidol University

Recruiting

Comparison Efficacy Between Two Different Frequency of Maintenance Dose Oral Immunotherapy

Immunotherapy | Wheat Hypersensitivity

Thailand
RenJi Hospital
Shanghai Zhongshan Hospital; Ruijin Hospital

Recruiting

A Study of Cadonilimab（AK104） Plus Lenvatinib in Previous Immunotherapy Treated Advanced/Metastatic Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy

China
Peking Union Medical College Hospital

Recruiting

Durvalumab and Lenvatinib With or Without Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

Biliary Tract Neoplasms | Immunotherapy

China
Stephen Chan Lam

Recruiting

CXD101 in Immunotherapy-related Liver Cancer

HCC

Hong Kong
Central Hospital, Nancy, France

Not yet recruiting

Efficacy and Safety of Oral Cashew Nut Immunotherapy in Children (CAJESITO) (CAJESITO)

Allergy;Food | Allergy, Nut
Central Hospital, Nancy, France

Not yet recruiting

Efficacy and Safety of Cashew Nut Oral Immunotherapy in Children (CAJESITO2)

Food Allergy in Children

France
Fujian Medical University Union Hospital

Not yet recruiting

Immunotherapy Plus Chemotherapy vs. Chemoradiotherapy for Thoracic Squamous Esophageal Carcinoma

Chemotherapy | Radiation Therapy

China
AbbVie

Recruiting

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis (SELECT- SWITCH)

Rheumatoid Arthritis

United States, Japan, United Kingdom, Canada, Korea, Republic of, Puerto Rico, South Africa, Hungary, Bulgaria, Spain, Portugal, Chile, Croatia, France, Belgium, Germany, Greece, Romania, Brazil, Italy, Serbia, China, Colombia, Mexico
Guangdong Provincial People's Hospital
Shanghai Junshi Bioscience Co., Ltd.

Recruiting

Neoadjuvant Immunotherapy in Rare Mutations Localized NSCLC

Non-Small Cell Lung Cancer | BRAF V600 Mutation | MET Amplification | MET Exon 14 Skipping Mutation | RET Driver Mutation | Erb-B2 Receptor Tyrosine Kinase Exon 20 Mutation

China
Hospital of Stomatology, Wuhan University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma (NEOPCOSCC)

Oral Squamous Cell Carcinoma

China
Beijing Friendship Hospital

Recruiting

Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal Carcinoma

Esophageal Carcinoma | Neoadjuvant Immunotherapy

China
Tampere University Hospital
Oulu University Hospital; University of Oulu

Recruiting

Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16

Egg Allergy

Finland
ECOG-ACRIN Cancer Research Group
National Cancer Institute (NCI)

Recruiting

Combining Radiation Therapy With Immunotherapy for the Treatment of Metastatic Squamous Cell Carcinoma of the Head and Neck

Metastatic Head and Neck Squamous Cell Carcinoma | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 | Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 | Stage IV Hypopharyngeal Carcinoma AJCC v8 | Stage IV Laryngeal Cancer AJCC v8 | Stage... and other conditions

United States
Michael Dill
University of Cologne; German Cancer Research Center; Heidelberg University; Universitätsmedizin... and other collaborators

Not yet recruiting

Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) (FLORA)

Immunotherapy

Germany
Children's Hospital of Fudan University

Not yet recruiting

Rivaroxaban for Children With Giant Coronary Artery Aneurysms After Kawasaki Disease

Kawasaki Disease | Coronary Artery Aneurysm

China
Sun Yat-sen University

Recruiting

Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy

Advanced Hepatocellular Carcinoma

China
Chinese University of Hong Kong

Recruiting

Fish Oral Immunotherapy in Hong Kong Children

Food Allergy in Children | Fish Allergy

Hong Kong
Tongji Hospital

Recruiting

Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC

Hepatocellular Carcinoma | Effects of Immunotherapy | Programmed Cell Death 1

China
University of Erlangen-Nürnberg Medical School
University Hospital Erlangen; University Hospital Regensburg; University Hospital...

Recruiting

Immune Biomarker Study for Head and Neck Cancer (ImmunBio-KHT)

Head and Neck Cancer | Laryngeal Cancer | Hypopharyngeal Cancer | Oropharyngeal Cancer | Oral Cavity Cancer

Germany
Jiuda Zhao
Second Hospital of Lanzhou University

Recruiting

A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer

Gastric Cancer | Chemotherapy | Immunotherapy

China
National Cancer Institute (NCI)

Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

Head and Neck Squamous Cell Carcinoma | Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma | Metastatic... and other conditions

United States
Medical University of Warsaw

Recruiting

Induction of Sustained Unresponsiveness to Peanuts Using High- and Low-dose Peanut Oral Immunotherapy

Peanut Allergy

Poland
Medical University of Warsaw

Recruiting

High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety (Sesame)

Food Allergy

Poland
University of Chicago

Recruiting

Pinpoint Trial: Prebiotics IN Peanut Oral ImmunoTherapy

Peanut Allergy

United States
Assistance Publique - Hôpitaux de Paris

Recruiting

New Clinical End-points in Patients With Primary Sjögren's Syndrome (NECESSITY)

Primary Sjögren's Syndrome (pSS)

France
Murdoch Childrens Research Institute

Recruiting

Low Dose Multi-Nut Oral Immunotherapy in Pre-schoolers With a Multi-Nut Allergy (LMNOP)

Allergy, Nut

Australia
André Luiz Malavasi Longo de Oliveira
Science Valley Research Institute

Recruiting

Venous Thromboembolism Prophylaxis After Gynecological Pelvic Cancer Surgery With Rivaroxaban vs Enoxaparin (VALERIA)

Cancer | Venous Thromboembolism | Rivaroxaban | Thromboprophylaxis

Brazil
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Recruiting

First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients

Head Neck Cancer | Oropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Metastatic Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell Carcinoma

United States
Oslo University Hospital

Recruiting

Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

Celiac Disease

Norway
University of Minnesota
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Recruiting

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

Smoking | Smoking Cessation | Smoking Reduction

United States
Ohio State University Comprehensive Cancer Center

Recruiting

Combining Immunotherapy Salvage Surgery & IORT Tx Persistent/Recurrent Head & Neck Cancer

Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Pharyngeal Squamous Cell Carcinoma | Locally Recurrent Head and Neck Squamous Cell Carcinoma | Head and Neck Carcinoma of Unknown Primary | Resectable Head and Neck Squamous Cell Carcinoma

United States
National Cancer Institute (NCI)

Recruiting

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Recurrent Head and Neck Squamous Cell Carcinoma | Recurrent Hypopharyngeal Squamous Cell Carcinoma | Recurrent Laryngeal Squamous Cell Carcinoma | Recurrent Oral Cavity Squamous Cell Carcinoma | Recurrent Oropharyngeal Squamous Cell Carcinoma

United States
Peking Union Medical College Hospital
AstraZeneca

Recruiting

Mechanism of Response to IMFINZI Neoadjuvant Therapy in Non-small Cell Lung Cancer Patients Based on Multiple-omics Models

Non-small Cell Lung Cancer

China
McGill University Health Centre/Research Institute...

Recruiting

Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)

Lung Cancer, Nonsmall Cell

Canada
Cliniques universitaires Saint-Luc- Université...

Recruiting

Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck. (HN1901)

Oropharynx Squamous Cell Carcinoma | Oral Cavity Squamous Cell Carcinoma | Hypopharynx Squamous Cell Carcinoma | Larynx Squamous Cell Carcinoma

Belgium
Medical University of Warsaw

Recruiting

High and Low Dose Oral Peanut Immunotherapy - Comparison of Efficacy and Safety

Peanut Allergy

Poland
Syntrix Biosystems, Inc.
Johns Hopkins University; Mayo Clinic; National Heart, Lung, and Blood Institute... and other collaborators

Recruiting

Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome

Myelodysplastic Syndromes

United States
Andrew J Long, PharmD
Regeneron Pharmaceuticals; Robert Levin Charitable Fund

Recruiting

Dupilumab and Milk OIT for the Treatment of Cow's Milk Allergy

Allergies Food Milk

United States
Maxinovel Pty., Ltd.

Recruiting

MAX-10181 Given Orally to Patients With Advanced Solid Tumor

Solid Tumor

Australia

Search clinical trials for: Multi-allergen oral immunotherapy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations